To evaluate whether certain miRNAs are dysregulated with the various clinical and histopathological features associated with breast cancer, we analyzed our data by nonparametric statistical tests (Mann-Whitney U and Kruskal-Wallis tests) after dividing the samples into groups with differential ER or PR expression or Her2 overexpression, lymph node involvement, tumor size and grade. This evidence concerns the gene PGR and breast cancer.